FFS
AGN

Founders Financial Securities’s Allergan plc AGN Stock Holding History

Founders Financial Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,300
Closed -$630K – 132
2019
Q1 		$630K Buy
4,300
+84
+2% +$12.2K 0.2% 77
2018
Q4 		$564K Buy
4,216
+75
+2% +$12.3K 0.2% 71
2018
Q3 		$789K Buy
4,141
+36
+0.9% +$6.61K 0.22% 62
2018
Q2 		$684K Buy
+4,105
New +$659K 0.21% 69

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Founders Financial Securities's AGN Position: Q2 2019 in Review

Founders Financial Securities sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 4,300 shares — an estimated $630K sold.

Founders Financial Securities first reported a position in AGN in Q2 2018 and held it in 4 quarters. The position peaked at $789K in Q3 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Founders Financial Securities reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Founders Financial Securities sold 4,300 Allergan plc shares in Q2 2019, an estimated $630K.
  • Founders Financial Securities first reported a position in Allergan plc in Q2 2018 and held it in 4 quarters.
  • Founders Financial Securities's Allergan plc position peaked at $789K in Q3 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Founders Financial Securities's 13F filing for Q2 2019, filed 22 Jul 2019.